Canada's Valeant Pharmaceuticals International said on Thursday it would buy Sprout Pharmaceuticals, maker of the first approved treatment for low sexual desire in women, for about $1 billion plus milestone payments.
Valeant Pharmaceuticals International said it would boost its takeover bid for Botox-maker Allergan for the second time this week, contingent on the two sides negotiating.
Laval, Quebec-based Valeant said it would pay $72 in cash
The US Food and Drug Administration gave its limited approval on Monday for GlaxoSmithKline's and Valeant Pharmaceuticals International's new epilepsy drug Potiga.
The drug, known generically as ezogabine, will not be availab